{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:01:39Z","timestamp":1791378099933,"version":"4.3.2"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T00:00:00Z","timestamp":1590278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T00:00:00Z","timestamp":1590278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012895","name":"Zoetis","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100012895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Buprenorphine is used for canine postoperative pain management. This study aimed to describe the pharmacokinetics and evaluate the analgesic efficacy of buprenorphine (Simbadol, 1.8\u2009mg\/mL) administered by different routes in dogs undergoing ovariohysterectomy. Twenty-four dogs were included in a randomized, prospective, masked, clinical trial. Buprenorphine (0.02\u2009mg\/kg) was administered intravenously (IV), intramuscularly (IM) or subcutaneously (SC) (<jats:italic>n<\/jats:italic>\u2009=\u20098\/group) 0.5\u2009h before general anesthesia with propofol-isoflurane. Carprofen (4.4\u2009mg\/kg SC) was administered after anesthetic induction and before ovariohysterectomy. Pain was scored using the short-form Glasgow composite pain scale for dogs (SF-GCPS). Dogs were administered morphine (0.25\u2009mg\/kg IV) when SF-GCPS scores were\u2009\u2265\u20095\/20. Blood sampling was performed up to 720\u2009min after drug administration. Plasma buprenorphine and norbuprenorphine concentrations were analyzed using liquid chromatography mass spectrometry. Pharmacokinetics of buprenorphine was described using a non-compartmental model (PK Solver 2.0). Statistical analysis was performed using linear mixed models and Fisher\u2019s exact test (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Pain scores were significantly higher than baseline after IV (0.5\u20132\u2009h), IM (0.5\u20133\u2009h) and SC (0.5\u20134\u2009h) but not among groups. Prevalence of rescue analgesia was significantly higher in SC (7\/8 dogs) than IV (2\/8) but not different between IV and IM (3\/8) or IM and SC. The frequency of rescue analgesia was not significantly different among groups (IV\u2009=\u20092, IM\u2009=\u20095 and SC\u2009=\u20099). Norbuprenorphine was not detected. For IV, IM and SC administration, clearance was 1.29, 1.65 and 1.40\u2009L\/hour\/kg, volume of distribution was 6.8, 14.2 and 40.1\u2009L\/kg, the elimination half-life was 3.7, 5.7, 22\u2009h, and the area under the plasma concentration-time curved extrapolated to infinity was 15.7, 12.4 and 16.4\u2009ng\/mL\/hour, respectively. Bioavailability for IM and SC was 62.6 and 40%, respectively. Maximum plasma concentrations of buprenorphine were 6.2 and 1.3\u2009ng\/mL at 0.14 and 0.33\u2009h after IM and SC administration, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The route of administration influences the analgesic efficacy of buprenorphine in dogs. SC administration of buprenorphine failed to provide clinical analgesia due to erratic drug absorption. At the doses administered, the IV and IM routes are preferred for postoperative analgesia.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12917-020-02364-w","type":"journal-article","created":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T10:02:33Z","timestamp":1590314553000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Pharmacokinetics and analgesic effects of intravenous, intramuscular or subcutaneous buprenorphine in dogs undergoing ovariohysterectomy: a randomized, prospective, masked, clinical trial"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4150-6043","authenticated-orcid":false,"given":"Paulo Vinicius","family":"Steagall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne Louise Marcelle","family":"Ruel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyo","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz Paglerani","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Cayetano","family":"Evangelista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Beaudry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,24]]},"reference":[{"issue":"9","key":"2364_CR1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/jsap.12859","volume":"59","author":"MD Shah","year":"2018","unstructured":"Shah MD, Yates D, Hunt J, Murrell JC. A comparison between methadone and buprenorphine for perioperative analgesia in dogs undergoing ovariohysterectomy. J Small Anim Pract. 2018;59(9):539\u201346.","journal-title":"J Small Anim Pract"},{"issue":"8","key":"2364_CR2","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1177\/1098612X13476033","volume":"15","author":"PV Steagall","year":"2013","unstructured":"Steagall PV, Monteiro-Steagall BP. Multimodal analgesia for perioperative pain in three cats. J Feline Med Surg. 2013;15(8):737\u201343.","journal-title":"J Feline Med Surg"},{"issue":"4","key":"2364_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0176443","volume":"12","author":"GM Doodnaught","year":"2017","unstructured":"Doodnaught GM, Monteiro BP, Benito J, Edge D, Beaudry F, Pelligand L, Steagall P. Pharmacokinetic and pharmacodynamic modelling after subcutaneous, intravenous and buccal administration of a high-concentration formulation of buprenorphine in conscious cats. PLoS One. 2017;12(4):e0176443.","journal-title":"PLoS One"},{"key":"2364_CR4","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s12917-018-1628-4","volume":"14","author":"R Watanabe","year":"2018","unstructured":"Watanabe R, Monteiro BP, Evangelista MC, Castonguay A, Edge D, Steagall PV. The analgesic effects of buprenorphine (Vetergesic or Simbadol) in combination with carprofen in dogs undergoing ovariohysterectomy: a randomized, blinded, clinical trial. BMC Vet Res. 2018;14:304.","journal-title":"BMC Vet Res"},{"issue":"3","key":"2364_CR5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.tvjl.2008.03.001","volume":"181","author":"A Andaluz","year":"2009","unstructured":"Andaluz A, Moll X, Abell\u00e1n R, et al. Pharmacokinetics of buprenorphine after intravenous administration of clinical doses to dogs. Vet J. 2009;181(3):299\u2013304.","journal-title":"Vet J"},{"issue":"4","key":"2364_CR6","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/jvp.12497","volume":"41","author":"M Barletta","year":"2018","unstructured":"Barletta M, Ostenkamp SM, Taylor AC, Quandt J, Lascelles BDX, Messenger KM. The pharmacokinetics and analgesic effects of extended-release buprenorphine administered subcutaneously in healthy dogs. J Vet Pharmacol Ther. 2018;41(4):502\u201312.","journal-title":"J Vet Pharmacol Ther"},{"issue":"6","key":"2364_CR7","doi-asserted-by":"publisher","first-page":"722","DOI":"10.2460\/ajvr.69.6.722","volume":"69","author":"U Krotscheck","year":"2008","unstructured":"Krotscheck U, Boothe DM, Little AA. Pharmacokinetics of buprenorphine following intravenous administration in dogs. Am J Vet Res. 2008;69(6):722\u20137.","journal-title":"Am J Vet Res"},{"issue":"3","key":"2364_CR8","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.tvjl.2010.01.013","volume":"187","author":"K Pieper","year":"2011","unstructured":"Pieper K, Schuster T, Levionnois O, Matis U, Bergadano A. Antinociceptive efficacy and plasma concentrations of transdermal buprenorphine in dogs. Vet J. 2011;187(3):335\u201341.","journal-title":"Vet J"},{"issue":"1","key":"2364_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1467-2995.2012.00779.x","volume":"40","author":"PV Steagall","year":"2013","unstructured":"Steagall PV, Pelligand L, Giordano T, Auberger C, Sear JW, Luna SP, Taylor PM. Pharmacokinetic and pharmacodynamic modelling of intravenous, intramuscular and subcutaneous buprenorphine in conscious cats. Vet Anaesth Analg. 2013;40(1):83\u201395.","journal-title":"Vet Anaesth Analg"},{"issue":"4","key":"2364_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1467-2995.2010.00541.x","volume":"37","author":"T Giordano","year":"2010","unstructured":"Giordano T, Steagall PV, Ferreira TH, Minto BW, de S\u00e1 Lorena SE, Brondani J, Luna SP. Postoperative analgesic effects of intravenous, intramuscular, subcutaneous or oral transmucosal buprenorphine administered to cats undergoing ovariohysterectomy. Vet Anaesth Analg. 2010;37(4):357\u201366.","journal-title":"Vet Anaesth Analg"},{"issue":"4","key":"2364_CR11","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1177\/1098612X15581206","volume":"18","author":"PM Taylor","year":"2016","unstructured":"Taylor PM, Luangdilok CH, Sear JW. Pharmacokinetic and pharmacodynamic evaluation of high doses of buprenorphine delivered via high-concentration formulations in cats. J Feline Med Surg. 2016;18(4):290\u2013302.","journal-title":"J Feline Med Surg."},{"issue":"3","key":"2364_CR12","doi-asserted-by":"publisher","first-page":"318","DOI":"10.2460\/javma.238.3.318","volume":"238","author":"JC Ko","year":"2011","unstructured":"Ko JC, Freeman LJ, Barletta M, Weil AB, Payton ME, Johnson BM, Inoue T. Efficacy of oral transmucosal and intravenous administration of buprenorphine before surgery for postoperative analgesia in dogs undergoing ovariohysterectomy. J Am Vet Med Assoc. 2011;238(3):318\u201328.","journal-title":"J Am Vet Med Assoc"},{"issue":"1","key":"2364_CR13","first-page":"48","volume":"52","author":"EA Nunamaker","year":"2013","unstructured":"Nunamaker EA, Halliday LC, Moody DE, Fang WB, Lindeblad M, Fortman JD. Pharmacokinetics of 2 formulations of buprenorphine in macaques (Macaca mulatta and Macaca fascicularis). J Am Assoc Lab Anim Sci. 2013;52(1):48\u201356.","journal-title":"J Am Assoc Lab Anim Sci"},{"issue":"21","key":"2364_CR14","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1136\/vr.159.21.705","volume":"159","author":"LS Slingsby","year":"2006","unstructured":"Slingsby LS, Taylor PM, Waterman-Pearson AE. Effects of two doses of buprenorphine four or six hours apart on nociceptive thresholds, pain and sedation in dogs after castration. Vet Rec. 2006;159(21):705\u201311.","journal-title":"Vet Rec"},{"issue":"6","key":"2364_CR15","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/j.1467-2995.2011.00656.x","volume":"38","author":"LS Slingsby","year":"2011","unstructured":"Slingsby LS, Taylor PM, Murrell JC. A study to evaluate buprenorphine at 40 \u03bcg kg(\u22121) compared to 20 \u03bcg kg(\u22121) as a post-operative analgesic in the dog. Vet Anaesth Analg. 2011;38(6):584\u201393.","journal-title":"Vet Anaesth Analg"},{"issue":"6","key":"2364_CR16","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1467-2995.2006.00285.x","volume":"33","author":"LA Goyenechea Jaramillo","year":"2006","unstructured":"Goyenechea Jaramillo LA, Murrell JC, Hellebrekers LJ. Investigation of the interaction between buprenorphine and sufentanil during anaesthesia for ovariectomy in dogs. Vet Anaesth Analg. 2006;33(6):399\u2013407.","journal-title":"Vet Anaesth Analg"},{"issue":"3","key":"2364_CR17","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.vaa.2016.05.010","volume":"44","author":"A Barbarossa","year":"2017","unstructured":"Barbarossa A, Rambaldi J, Giunti M, Zaghini A, Cunto M, Zambelli D, Valgimigli S, Santoro F, Romagnoli N. Pharmacokinetics of buprenorphine following constant rate infusion for postoperative analgesia in dogs undergoing ovariectomy. Vet Anaesth Analg. 2017;44(3):435\u201343.","journal-title":"Vet Anaesth Analg"},{"issue":"2","key":"2364_CR18","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1124\/jpet.106.115972","volume":"321","author":"A Yassen","year":"2007","unstructured":"Yassen A, Kan J, Olofsen E, Suidgeest E, Dahan A, Danhof M. Pharmacokinetic-pharmacodynamic modeling of the respiratory depressant effect of norbuprenorphine in rats. J Pharmacol Exp Ther. 2007;321(2):598\u2013607.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"2364_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/jsap.13084","volume":"61","author":"PVM Steagall","year":"2020","unstructured":"Steagall PVM, Benito J, Monteiro B, Lascelles D, Kronen PW, Murrell JC, Robertson S, Wright B, Yamashita K. Intraperitoneal and incisional analgesia in small animals: simple, cost-effective techniques. J Small Anim Pract. 2020;61(1):19\u201323.","journal-title":"J Small Anim Pract"},{"key":"2364_CR20","doi-asserted-by":"publisher","first-page":"c332","DOI":"10.1136\/bmj.c332","volume":"340","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D. CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332.","journal-title":"BMJ"},{"issue":"S","key":"2364_CR21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1017\/S096272860003178X","volume":"16","author":"J Reid","year":"2007","unstructured":"Reid J, Nolan AM, Hughes JML, Lascelles D, Pawson P, Scott EM. Development of the short-form Glasgow composite measure pain scale (CMPS-SF) and derivation of an analgesic intervention score. Anim Welf. 2007;16(S):97\u2013104.","journal-title":"Anim Welf"},{"issue":"3","key":"2364_CR22","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.1467-2995.2011.00609.x","volume":"38","author":"JB Camargo","year":"2011","unstructured":"Camargo JB, Steagall PVM, Minto BW, de Lorena SER S, Mori ES, Luna SPL. Post-operative analgesic effects of butorphanol or firocoxib administered to dogs undergoing elective ovariohysterectomy. Vet Anaesth Analg. 2011;38(3):252\u20139.","journal-title":"Vet Anaesth Analg"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-020-02364-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-020-02364-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-020-02364-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T12:09:23Z","timestamp":1696162163000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-020-02364-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,24]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2364"],"URL":"https:\/\/doi.org\/10.1186\/s12917-020-02364-w","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,24]]},"assertion":[{"value":"8 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This project has been approved by the local animal care committee of the Universit\u00e9 de Montr\u00e9al (18-Rech-1979). Written informed consent was obtained from the shelters before enrollment.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Paulo Steagall has received speaker honoraria and provided consultancy services to Zoetis. Dr. Beatriz Monteiro has provided consultancy services to Zoetis. This does not alter the authors\u2019 adherence to BMC Veterinary Research policies on sharing data and materials, nor the decision to publish the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"154"}}